Claris Advisors’s Gilead Sciences GILD Stock Holding History

Claris Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20	Closed	-$1.68K	–	492
2024 Q3	$1.68K	Buy	+20	New	+$1.53K	﹤0.01%	345

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Claris Advisors's GILD Position: Q4 2024 in Review

Claris Advisors sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 20 shares — an estimated $1.68K sold.

Claris Advisors first reported a position in GILD in Q3 2024 and held it in 1 quarter. The position peaked at $1.68K in Q3 2024. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Claris Advisors reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
Claris Advisors sold 20 Gilead Sciences shares in Q4 2024, an estimated $1.68K.
Claris Advisors first reported a position in Gilead Sciences in Q3 2024 and held it in 1 quarter.
Claris Advisors's Gilead Sciences position peaked at $1.68K in Q3 2024.
1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Claris Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.